HOLX vs PFE · P/E 32, rev $4.10B vs P/E 20, rev $15.03B
Hologic Inc (HOLX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla D.V.M., Ph.D..
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
HOLX currently screens at market cap $16.97B and trailing P/E 31.5. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the HOLX and PFE stock pages for the full models.
Not investment advice.